Treatment with topical cyclosporine 0.1% after therapeutic penetrating keratoplasty (TPK) seems to increase graft survival and postoperative vision with reduced risk of recurrence of primary infection, according to a study published in Cornea.

In earlier research, investigators observed a high graft failure rate after TPK in eyes with fungal keratitis. Postoperative inflammation was one of the major reasons for graft failure in other eyes in the study. Investigators in the current study hypothesized that controlling the immediate postoperative inflammation with an agent that did not simultaneously promote fungal recurrence would increase the chance of graft survival.

Researchers launched a prospective case series to test the efficacy and safety of topical cyclosporine 0.1% in preventing early graft failure. The study included patients with fungal keratitis undergoing TPK between May and December 2019 treated with cyclosporine A 0.1% eye drops (tCSA group). They compared the outcomes with a historical cohort of patients treated conventionally with topical prednisolone acetate 1% eye drops started 3 weeks after surgery (CT group).


Continue Reading

There were 20 patients (13 men) in the tCSA group and 28 patients (23 men) in the CT group. The number of clear grafts 3 months postoperatively was 10 (50%) in the tCSA group and 4 (14.3%) in the CT group (P =.011). The mean logarithm of the minimum angle of resolution best-corrected visual acuity was 1.49±0.74 in the tCSA group and 2.10±0.62 in the CT group (P =.003). There were 5 patients (17.9%) with recurrence of the primary fungal infection in the CT group, 4 of whom used topical prednisolone. There was no recurrence in the tCSA group. Analysis revealed higher odds of a clear graft at 3 months postoperatively with topical cyclosporine 0.1% (P =.004).

There were several limitations to this study, including the use of a historical cohort as a control group, a difference in the duration of preservation of the donor corneas, that the treatment group was smaller than the historical control group, and the early use of topical prednisolone.

Reference

Chatterjee S, Agrawal D. Use of topical cyclosporine 0.1% in therapeutic penetrating keratoplasty for fungal keratitis. Cornea. Published online September 4, 2021. doi:10.1097/ICO.0000000000002827